Clinical and genomic signatures of rising SARS-CoV-2 Delta breakthrough infections in New York

In 2021, Delta has become the predominant SARS-CoV-2 variant worldwide. While vaccines effectively prevent COVID-19 hospitalization and death, vaccine breakthrough infections increasingly occur. The precise role of clinical and genomic determinants in Delta infections is not known, and whether they...

Descripción completa

Detalles Bibliográficos
Autores principales: Duerr, Ralf, Dimartino, Dacia, Marier, Christian, Zappile, Paul, Levine, Samuel, François, Fritz, Iturrate, Eduardo, Wang, Guiqing, Dittmann, Meike, Lighter, Jennifer, Elbel, Brian, Troxel, Andrea B., Goldfeld, Keith S., Heguy, Adriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669846/
https://www.ncbi.nlm.nih.gov/pubmed/34909779
http://dx.doi.org/10.1101/2021.12.07.21267431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669846/
https://www.ncbi.nlm.nih.gov/pubmed/34909779
http://dx.doi.org/10.1101/2021.12.07.21267431

Ejemplares similares